6-K
Cybin Inc.
A Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health conditions such as depression and anxiety. It engineers lab-modified versions of naturally occurring compounds, including psilocybin—the mushroom molecule behind the company's name. Founded in 2019, the firm later rebranded as Helus Pharma, pronounced "heal us."